MS-347a
MS-347a is an inhibitor of myosin light chain kinase (MLCK) and protein kinase C (PKC), with IC50 values of 9.2 μM, 31 μM and 16 μM against calmodulin-dependent MLCK, calmodulin-independent MLCK and PKC, respectively. MS-347a binds to the catalytic domain of MLCK and blocks both calmodulin-dependent and calmodulin-independent MLCK activity. MS-347a inhibits the growth of drug-sensitive fission yeast and multiple ascomycete phytopathogenic fungi. MS-347a exhibits fungicidal activity against a variety of phytopathogenic fungi and protective activity against Magnaporthe oryzae in rice seedlings. MS-347a shows antibacterial activity against specific Gram-positive bacteria and Proteus vulgaris. MS-347a can be used in studies related to rice blast, bacterial infections and phytopathogenic fungal diseases.
For research use only. We do not sell to patients.
- CAS No.: 144678-18-2
- Formula: C16H12O7
- Molecular Weight:316.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
PKC 16 μM (IC50) |
MLCK 9.2 μM (IC50, Calmodulin-dependent MLCK activity) |
MLCK 31 μM (IC50, Calmodulin-independent MLCK activity) |
In Vitro
MS-347a (10-40 min) potently inhibits calmodulin-dependent chicken gizzard myosin light chain kinase (MLCK) with an IC50 value of 9.2 μM, and this inhibitory effect is time-dependent, reaching a peak after pre-incubation at a concentration of 15 μM for 20 minutes[1].
MS-347a inhibits calmodulin-independent trypsin-digested chicken gizzard myosin light chain kinase (MLCK) with an IC50 of 31 μM[1].
MS-347a inhibits protein kinase C in rat brain with an IC50 of 16 μM; at concentrations up to 150 μM, it does not inhibit calmodulin-dependent cyclic nucleotide phosphodiesterase, cAMP-dependent protein kinase, or cGMP-dependent protein kinase[1].
MS-347a (0.4-100 μg/mL) exhibits antibacterial activity against Gram-positive bacteria and *Proteus vulgaris* ATCC 6897, with MIC values ranging from 0.4 to 3.0 μg/mL. However, at the highest concentration of 100 μg/mL, it shows no activity against Gram-negative bacteria (except *Proteus vulgaris*) and *Candida albicans*[1].
MS-347a (0.03-10 µg/disk; 3 days) exhibits broad-spectrum antifungal activity against Pyricularia oryzae APU15-60A (QoIS), Pyricularia oryzae APU15-63A (QoIR), Botrytis cinerea MAFF-306820, Leptosphaeria maculans MAFF-726728, and Colletotrichum gloeosporioides MAFF-237219. Among these pathogens, the largest inhibition zone, reaching 24.19 mm, is observed against Pyricularia oryzae APU15-60A (QoIS) at the dose of 10 µg/disk[3].
MS-347a (1-30 μg/disk; 3 days) exhibits potent antifungal activity against Saccharomyces cerevisiae BY4741 12gene-0HSR-iERG6, and its activity in YPG medium (inhibition zone diameter of 15.7 mm at 30 μg/disk) is higher than that in YPD medium (inhibition zone diameter of 11 mm at 30 μg/disk)[2].
MS-347a (0.01-10 μg/disk; 3 days) exhibits broad-spectrum antifungal activity against plant pathogenic fungi belonging to Ascomycota, and is effective against both QoI-sensitive and QoI-resistant Pyricularia oryzae strains. Among these, it shows the strongest activity against the QoI-sensitive Pyricularia oryzae strain APU15-60A, with an inhibition zone diameter of 25.91 mm at 10 μg/disk[2].
MS-347a (up to 128 μg/mL) selectively inhibits the growth of drug-hypersensitive fission yeast (S. pombe 7Δ) with an MIC of 1 μg/mL; it exhibits a selectivity up to 32-fold over multidrug-sensitive budding yeast (S. cerevisiae 12geneΔ0HSR-iERG6), and shows no activity against wild-type fission yeast, 2Δ fission yeast, or wild-type budding yeast at concentrations up to 128 μg/mL[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 144678-18-2
-
Molecular Weight 316.26
-
Formula C16H12O7
-
SMILES
O=C(C12OC1C=CC(OC3=CC(CO)=CC(O)=C34)=C2C4=O)OC
-
Structure Classification
-
Initial Source
Aspergillus sp.
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
[1]. Nakanishi S, et al. MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178. The Journal of antibiotics. 1993 Dec;46(12):1775-81. [Content Brief]
[2]. Honma S, et al. Re-discovery of MS-347a as a Fungicide Candidate through a New Drug Discovery Platform with a Multidrug-Sensitive Saccharomyces cerevisiae Screening System and the Introduction of a Global Secondary Metabolism Regulator, laeA Gene. Biosci Biotechnol Biochem. 2024;88:824-829. [Content Brief]
[3]. Kimishima A, et al. Synthesis and biological evaluation of MS-347a derivatives against plant pathogenic fungi based on a strategy of gene introduction. Journal of pesticide science. 2024 Nov 20;49(4):224-231. [Content Brief]
[4]. Kimishima A, et al. Construction of a New Drug and Agrochemical Candidates Screening Platform Utilizing Drug-Hypersensitive Fission Yeast to Discover Overlooked Natural Products. Journal of natural products. 2025 Sep 26;88(9):2090-2096. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)